Tags |
|
|
Links |
|
|
Digg It - Effortless Networking: How to Connect With Someone Quickly
"How do I connect with someone quickly?"
This may seem like a simple question, but it's actu
This may seem like a simple question, but it's actu
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ally a little more complex -- and perhaps you know that already. When I work privately with c
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ients on such a topic, it takes a few months!
Still, here are two steps you can take right a
Still, here are two steps you can take right a
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ay, to connect quickly with someone, no matter what the situation.
- What a
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
e you listening for?
In other words, how will you know when you've "connected" with
In other words, how will you know when you've "connected" with
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
someone?
For instance, will you recognize the "connection" when you hear the other person sa
For instance, will you recognize the "connection" when you hear the other person sa
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
something in particular? Or when he or she has a certain facial expression? Or when you feel
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
a particular way physically (i.e. gut feeling)? And so on.
If you take the time upfront to f
If you take the time upfront to f
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
gure this out, when you're talking with someone you'll be able to more easily recognize these
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
moments -- and take advantage of them.
This may not necessarily be a simple question to answ
This may not necessarily be a simple question to answ
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
r. But when you do, it'll serve you well in many different contexts.
Lis
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ten for it!
Pay attention and actively look out for opportunities to "connect", as
Pay attention and actively look out for opportunities to "connect", as
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ou've defined above.
This seems obvious, but it can be a difficult step!
When we start talk
This seems obvious, but it can be a difficult step!
When we start talk
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ng with someone, we start with the best of intentions.
But then we get distracted.
We start
But then we get distracted.
We start
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
thinking about other things, or spacing out, or rehearsing in our heads what we'll say next,
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
nd so on.
If you're doing this, you're not really participating in the conversation you're i
If you're doing this, you're not really participating in the conversation you're i
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
. Not only that, you're probably also missing big chunks of what the other person is saying -
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
and along with it, missing opportunities to connect.
So practice staying present in the con
So practice staying present in the con
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ersations you're having.
And next time you want to connect with someone quickl
And next time you want to connect with someone quickl
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
, follow these 2 steps.
It's amazing how much mileage you can get from such a simple process
It's amazing how much mileage you can get from such a simple process
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/31744/diggit-Effortless-Networking-How-to-Connect-With-Someone-Quickly.html">Effortless Networking: How to Connect With Someone Quickly</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/31744/diggit-Effortless-Networking-How-to-Connect-With-Someone-Quickly.html]Effortless Networking: How to Connect With Someone Quickly[/url]
Related Articles:
Being Creative With Your Fundraising Ideas
Bookmark it:
|